Generic Name and Formulations:
Travoprost 0.004%; oph soln; contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
Company:
Alcon Laboratories, Inc.
Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.
≥16yrs: 1 drop once daily in the PM.
<16yrs: not recommended.
Prostaglandin analogue.
Do not exceed recommended dose. Active intraocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Benzalkonium chloride may be absorbed by contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers.
Allow at least 5 minutes between application of other topical ophthalmic agents.
Ocular hyperemia, decreased visual acuity; eye discomfort, pain or itching; foreign body sensation, other local reactions, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, abnormal vision, blepharitis, cataract, conjunctivitis, keratitis, photophobia, allergy, angina, bradycardia, headache.
Soln—2.5mL, 5mL